All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Rho-associated kinases (ROCK) 1 and 2 are involved in the regulation of cytoskeletal dynamics and contraction, as well as leukocyte migration and loosening of endothelial and epithelial tight junctions. ROCK inhibition is an attractive and promising target and has been clinically evaluated in patients with GvHD.